Aoxing Pharmaceutical Company Inc (AOXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2016 | 06-2015 | 06-2014 | 06-2013 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,061 | 5,495 | -8,216 | -16,804 | -15,820 |
| Depreciation Amortization | 1,026 | 666 | 990 | 1,731 | 1,080 |
| Income taxes - deferred | 642 | -2,704 | 0 | N/A | N/A |
| Accounts receivable | -6,692 | -1,735 | -1,932 | -55 | -764 |
| Accounts payable and accrued liabilities | -2,207 | 1,352 | 455 | 585 | 40 |
| Other Working Capital | -5,527 | -805 | -1,106 | -302 | -680 |
| Other Operating Activity | 10,162 | 758 | 2,078 | 6,528 | 14,819 |
| Operating Cash Flow | $-535 | $3,026 | $-7,730 | $-8,317 | $-1,326 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -118 | -2,705 | -269 | -439 | -752 |
| Investing Cash Flow | $-118 | $-2,705 | $-269 | $-439 | $-752 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -437 | 1,029 | 8,046 | -433 | 2,894 |
| Debt Issued | 645 | 9,407 | 6,804 | 10,221 | -72 |
| Debt Repayment | N/A | N/A | -8,537 | -796 | N/A |
| Common Stock Issued | 2,739 | 2,424 | 0 | N/A | N/A |
| Other Financing Activity | 0 | -10,187 | 0 | 0 | 0 |
| Financing Cash Flow | $2,947 | $2,673 | $6,313 | $8,992 | $2,821 |
| Exchange Rate Effect | -753 | 49 | 8 | 90 | 169 |
| Beginning Cash Position | 5,372 | 2,330 | 4,008 | 3,683 | 2,771 |
| End Cash Position | 6,912 | 5,372 | 2,330 | 4,008 | 3,683 |
| Net Cash Flow | $1,541 | $3,042 | $-1,678 | $325 | $912 |
| Free Cash Flow | |||||
| Operating Cash Flow | -535 | 3,026 | -7,730 | -8,317 | -1,326 |
| Capital Expenditure | -118 | -2,705 | -269 | -439 | -752 |
| Free Cash Flow | -653 | 320 | -7,999 | -8,757 | -2,079 |